Application 021444
- Type
- NDA
- Sponsor
- JANSSEN PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | RISPERDAL | RISPERIDONE | TABLET, ORALLY DISINTEGRATING;ORAL | 0.5MG | Yes | No |
| 002 | RISPERDAL | RISPERIDONE | TABLET, ORALLY DISINTEGRATING;ORAL | 1MG | Yes | Yes |
| 003 | RISPERDAL | RISPERIDONE | TABLET, ORALLY DISINTEGRATING;ORAL | 2MG | Yes | No |
| 004 | RISPERDAL | RISPERIDONE | TABLET, ORALLY DISINTEGRATING;ORAL | 3MG | Yes | No |
| 005 | RISPERDAL | RISPERIDONE | TABLET, ORALLY DISINTEGRATING;ORAL | 4MG | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021444-001 | RISPERDAL | RISPERIDONE | 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2003-04-02 | |
| N021444-002 | RISPERDAL | RISPERIDONE | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2003-04-02 | |
| N021444-003 | RISPERDAL | RISPERIDONE | 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2003-04-02 | |
| N021444-004 | RISPERDAL | RISPERIDONE | 3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2004-12-23 | |
| N021444-005 | RISPERDAL | RISPERIDONE | 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2004-12-23 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N021444-001 | RISPERDAL | 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2003-04-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021444-002 | RISPERDAL | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2003-04-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021444-003 | RISPERDAL | 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2003-04-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021444-004 | RISPERDAL | 3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2004-12-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021444-005 | RISPERDAL | 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2004-12-23 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021444-001 | RISPERDAL | 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2003-04-02 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021444-002 | RISPERDAL | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2003-04-02 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021444-003 | RISPERDAL | 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2003-04-02 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021444-004 | RISPERDAL | 3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2004-12-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021444-005 | RISPERDAL | 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2004-12-23 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021444-001 | RISPERDAL | 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2003-04-02 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021444-002 | RISPERDAL | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2003-04-02 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021444-003 | RISPERDAL | 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2003-04-02 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021444-004 | RISPERDAL | 3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2004-12-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021444-005 | RISPERDAL | 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2004-12-23 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021444-001 | RISPERDAL | 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2003-04-02 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021444-002 | RISPERDAL | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2003-04-02 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021444-003 | RISPERDAL | 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2003-04-02 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021444-004 | RISPERDAL | 3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2004-12-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021444-005 | RISPERDAL | 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2004-12-23 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021444-001 | RISPERDAL | 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2003-04-02 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021444-002 | RISPERDAL | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2003-04-02 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021444-003 | RISPERDAL | 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2003-04-02 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021444-004 | RISPERDAL | 3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2004-12-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021444-005 | RISPERDAL | 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2004-12-23 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021444-001 | RISPERDAL | 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2003-04-02 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021444-002 | RISPERDAL | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2003-04-02 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021444-003 | RISPERDAL | 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2003-04-02 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021444-004 | RISPERDAL | 3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2004-12-23 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021444-005 | RISPERDAL | 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2004-12-23 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021444-001 | RISPERDAL | 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2003-04-02 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021444-002 | RISPERDAL | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2003-04-02 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021444-003 | RISPERDAL | 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2003-04-02 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021444-004 | RISPERDAL | 3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2004-12-23 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021444-005 | RISPERDAL | 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2004-12-23 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021444-001 | RISPERDAL | 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2003-04-02 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021444-002 | RISPERDAL | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2003-04-02 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021444-003 | RISPERDAL | 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2003-04-02 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021444-004 | RISPERDAL | 3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2004-12-23 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021444-005 | RISPERDAL | 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 2004-12-23 | 5bbf6a4d5a75… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N021444-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N021444-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N021444-003 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N021444-004 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N021444-005 | AB | 1 | 74a2ff9319b5… |
| 2021-03-12 10:30 UTC | 2021-03 | N021444-001 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | N021444-002 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | N021444-003 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | N021444-004 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | N021444-005 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N021444-001 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N021444-002 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N021444-003 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N021444-004 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N021444-005 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N021444-001 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N021444-002 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N021444-003 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N021444-004 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N021444-005 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N021444-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N021444-002 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N021444-003 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N021444-004 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N021444-005 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N021444-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N021444-002 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N021444-003 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N021444-004 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N021444-005 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N021444-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N021444-002 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N021444-003 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N021444-004 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N021444-005 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Risperidone | RISPERIDONE | Janssen Pharmaceutical, Inc. | 701e1cd8-2868-4d29-85a9-a2212c88165f | 2026-06-12 | Boxed warning, Warnings, Adverse reactions | 50458-603 50458-601 50458-602 |
| RISPERDAL | RISPERIDONE | Janssen Pharmaceuticals, Inc. | 7e117c7e-02fc-4343-92a1-230061dfc5e0 | 2026-05-28 | Boxed warning, Warnings, Adverse reactions | 021444 NDA021444 50458-315 50458-335 50458-325 50458-355 50458-395 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 50458-315 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-315 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-315 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-315 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-315 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-315 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-315 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-315 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-315 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-315 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-315 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-325 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-325 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-325 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-325 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-325 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-325 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-325 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-325 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-325 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-325 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-325 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-335 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-335 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-335 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-335 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-335 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-335 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-335 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-335 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-335 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-335 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-335 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-355 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-355 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-355 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-355 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-355 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-355 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-355 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-355 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-355 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-355 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-355 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-395 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-395 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-395 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-395 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-395 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-395 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-395 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-395 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-395 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-395 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-395 | RISPERDAL M-TAB | risperidone | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-601 | Risperidone M-TAB | risperidone | Janssen Pharmaceutical, Inc. | NDA | Current |
| 50458-602 | Risperidone M-TAB | risperidone | Janssen Pharmaceutical, Inc. | NDA | Current |
| 50458-603 | Risperidone M-TAB | risperidone | Janssen Pharmaceutical, Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 83892 | SUPPL | 2025-10-23 |
| 81129 | SUPPL | 2025-02-07 |
| 81033 | SUPPL | 2025-02-06 |
| 72792 | SUPPL | 2022-12-05 |
| 72784 | SUPPL | 2022-12-05 |
| 66283 | SUPPL | 2021-02-18 |
| 66241 | SUPPL | 2021-02-17 |
| 61845 | SUPPL | 2020-02-07 |
| 61787 | SUPPL | 2020-02-06 |
| 57555 | SUPPL | 2019-02-13 |
| 57362 | SUPPL | 2019-01-28 |
| 55146 | SUPPL | 2018-08-09 |
| 55052 | SUPPL | 2018-07-30 |
| 47422 | SUPPL | 2017-03-02 |
| 47318 | SUPPL | 2017-02-24 |
| 15486 | SUPPL | 2016-03-03 |
| 5398 | SUPPL | 2016-03-03 |
| 27806 | SUPPL | 2014-05-09 |
| 15485 | SUPPL | 2014-04-29 |
| 42171 | SUPPL | 2013-06-03 |
| 21660 | SUPPL | 2013-06-03 |
| 36946 | SUPPL | 2012-08-03 |
| 5395 | SUPPL | 2012-08-03 |
| 5397 | SUPPL | 2012-03-13 |
| 23661 | ORIG | 2011-12-20 |
| 42172 | SUPPL | 2011-12-14 |
| 21661 | SUPPL | 2011-12-14 |
| 36947 | SUPPL | 2011-09-30 |
| 15482 | SUPPL | 2011-09-30 |
| 27802 | SUPPL | 2011-09-28 |
| 5396 | SUPPL | 2011-09-28 |
| 27801 | SUPPL | 2011-08-26 |
| 15481 | SUPPL | 2011-08-25 |
| 27805 | SUPPL | 2011-06-17 |
| 36945 | SUPPL | 2011-06-16 |
| 27804 | SUPPL | 2010-12-06 |
| 15484 | SUPPL | 2010-12-04 |
| 27803 | SUPPL | 2010-09-07 |
| 5394 | SUPPL | 2010-09-07 |
| 5393 | SUPPL | 2010-09-07 |
| 5392 | SUPPL | 2010-09-07 |
| 36944 | SUPPL | 2010-08-30 |
| 36943 | SUPPL | 2010-08-30 |
| 36941 | SUPPL | 2010-08-30 |
| 15483 | SUPPL | 2010-08-30 |
| 27800 | SUPPL | 2009-08-06 |
| 36942 | SUPPL | 2009-07-21 |
| 27799 | SUPPL | 2008-08-19 |
| 42170 | SUPPL | 2008-02-19 |
| 36940 | SUPPL | 2007-08-23 |
| 15480 | SUPPL | 2007-08-23 |
| 27798 | SUPPL | 2007-08-22 |
| 5391 | SUPPL | 2007-08-22 |
| 27797 | SUPPL | 2006-10-18 |
| 5389 | SUPPL | 2006-10-18 |
| 15479 | SUPPL | 2006-10-11 |
| 15477 | SUPPL | 2006-10-11 |
| 36939 | SUPPL | 2005-08-19 |
| 5390 | SUPPL | 2005-08-19 |
| 15478 | SUPPL | 2004-12-29 |
| 5388 | SUPPL | 2004-12-29 |
| 36938 | SUPPL | 2003-12-11 |
| 27795 | SUPPL | 2003-12-11 |
| 15476 | SUPPL | 2003-12-11 |
| 5385 | SUPPL | 2003-12-11 |
| 5387 | SUPPL | 2003-11-28 |
| 27796 | SUPPL | 2003-11-25 |
| 5386 | SUPPL | 2003-09-25 |
| 42169 | ORIG | 2003-07-15 |
| 27794 | ORIG | 2003-05-29 |
| 36937 | ORIG | 2003-04-07 |